136 related articles for article (PubMed ID: 1431220)
21. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures.
Ala-Kokko L; Rintala A; Savolainen ER
J Invest Dermatol; 1987 Sep; 89(3):238-44. PubMed ID: 3624897
[TBL] [Abstract][Full Text] [Related]
22. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
23. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
24. Lysine acetylsalicylate decreases proliferation and extracellular matrix gene expression rate in keloid fibroblasts in vitro.
Petri JB; Haustein UF
Eur J Dermatol; 2002; 12(3):231-5. PubMed ID: 11978562
[TBL] [Abstract][Full Text] [Related]
25. Keloid Pathogenesis: Potential Role of Cellular Fibronectin with the EDA Domain.
Andrews JP; Marttala J; Macarak E; Rosenbloom J; Uitto J
J Invest Dermatol; 2015 Jul; 135(7):1921-1924. PubMed ID: 25685931
[No Abstract] [Full Text] [Related]
26. Keloids show regional distribution of proliferative and degenerate connective tissue elements.
Bux S; Madaree A
Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294
[TBL] [Abstract][Full Text] [Related]
27. Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway.
Jiang Z; Yu Q; Xia L; Zhang Y; Wang X; Wu X; Gao Z
Cell Physiol Biochem; 2016; 40(1-2):207-218. PubMed ID: 27855376
[TBL] [Abstract][Full Text] [Related]
28. Analysis of HOX gene expression and the effects of HOXA9 overexpression in fibroblasts derived from keloid lesions and normal skin.
Hahn JM; McFarland KL; Combs KA; Anness MC; Supp DM
Wound Repair Regen; 2021 Sep; 29(5):777-791. PubMed ID: 33811779
[TBL] [Abstract][Full Text] [Related]
29. Effects of x-irradiation on survival and extracellular matrix gene expression of cultured keloid fibroblasts.
Lee KS; Jung JB; Ro YJ; Ryoo YW; Kim OB; Song JY
J Dermatol Sci; 1994 Aug; 8(1):33-7. PubMed ID: 7947490
[TBL] [Abstract][Full Text] [Related]
30. Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling.
Lee WJ; Lee JS; Ahn HM; Na Y; Yang CE; Lee JH; Hong J; Yun CO
Sci Rep; 2017 Nov; 7(1):15070. PubMed ID: 29118355
[TBL] [Abstract][Full Text] [Related]
31. microRNA deregulation in keloids: an opportunity for clinical intervention?
Yu X; Li Z; Chan MT; Wu WK
Cell Prolif; 2015 Dec; 48(6):626-30. PubMed ID: 26486103
[TBL] [Abstract][Full Text] [Related]
32. Keloid scars are formed by polyclonal fibroblasts.
Chevray PM; Manson PN
Ann Plast Surg; 2004 Jun; 52(6):605-8. PubMed ID: 15166997
[TBL] [Abstract][Full Text] [Related]
33. Keloid fibroblasts exhibit an altered response to TGF-beta.
Babu M; Diegelmann R; Oliver N
J Invest Dermatol; 1992 Nov; 99(5):650-5. PubMed ID: 1431230
[TBL] [Abstract][Full Text] [Related]
34. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin A for the treatment of keloids.
Gauglitz GG; Bureik D; Dombrowski Y; Pavicic T; Ruzicka T; Schauber J
Skin Pharmacol Physiol; 2012; 25(6):313-8. PubMed ID: 22948093
[TBL] [Abstract][Full Text] [Related]
37. High in situ mRNA levels of IL-22, TFG-β, and ARG-1 in keloid scars.
da Cunha Colombo Tiveron LR; da Silva IR; da Silva MV; Peixoto AB; Rodrigues DBR; Rodrigues V
Immunobiology; 2018 Dec; 223(12):812-817. PubMed ID: 30146129
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype.
Higgins PJ; Slack JK; Diegelmann RF; Staiano-Coico L
Exp Cell Res; 1999 May; 248(2):634-42. PubMed ID: 10222156
[TBL] [Abstract][Full Text] [Related]
39. miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts.
Kashiyama K; Mitsutake N; Matsuse M; Ogi T; Saenko VA; Ujifuku K; Utani A; Hirano A; Yamashita S
J Invest Dermatol; 2012 Jun; 132(6):1597-604. PubMed ID: 22358059
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
Seleit I; Bakry OA; Samaka RM; Tawfik AS
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
